BDNF mediates the neuroprotective effects of positive AMPA receptor modulators against MPP+-induced toxicity in cultured hippocampal and mesencephalic slices

Neuropharmacology

Volumn 56, Issue 5, 2009, Pages 876-885

  Jourdi, H ^a   Hamo, L ^a   Oka, T ^b   Seegan, A ^a   Baudry, M ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b DAIICHI SANKYO CO   (Japan)

Author keywords

Ampakine; BDNF; Calpain; Dopamine; Hippocampus; Mesencephalon; Tyrosine hydroxylase

Indexed keywords

2H,3H,6AH PYRROLIDINO[2'',1'' 3',2'] 1,3 OXAZINO[6',5' 5,4] BENZO[E]1,4 DIOXAN 10 ONE; AMPA RECEPTOR; BENZOXAZINE DERIVATIVE; BRAIN DERIVED NEUROTROPHIC FACTOR; BRAIN DERIVED NEUROTROPHIC FACTOR RECEPTOR; CALPAIN; CALPASTATIN; CX 614; LACTATE DEHYDROGENASE; PROPIDIUM IODIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN SLICE; CELL TYPE; CLINICAL PROTOCOL; CONTROLLED STUDY; DRUG MECHANISM; HIPPOCAMPUS; INCUBATION TIME; LACTATE DEHYDROGENASE BLOOD LEVEL; MESENCEPHALON; NEUROPROTECTION; NEUROTOXICITY; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; TISSUE CULTURE;

1-METHYL-4-PHENYLPYRIDINIUM; ALLOSTERIC REGULATION; ANIMALS; ANIMALS, NEWBORN; BRAIN-DERIVED NEUROTROPHIC FACTOR; CALPAIN; HIPPOCAMPUS; L-LACTATE DEHYDROGENASE; MESENCEPHALON; NEUROPROTECTIVE AGENTS; OXAZINES; PROTEIN-TYROSINE KINASES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, AMPA; TISSUE CULTURE TECHNIQUES;

EID: 63049099414     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2009.01.015     Document Type: Article

References (43)

1. An J.J., Gharami K., Liao G.Y., Woo N.H., Lau A.G., Vanevski F., Torre E.R., Jones K.R., Feng Y., Lu B., and Xu B. Distinct role of long 3′ UTR BDNF mRNA in spine morphology and synaptic plasticity in hippocampal neurons. Cell 134 1 (2008) 175-187
2. Arai A.C., and Kessler M. Pharmacology of ampakine modulators: from AMPA receptors to synapses and behavior. Curr. Drug Targets 8 5 (2007) 583-602
3. Bi X., Chen J., and Baudry M. Developmental changes in calpain activity, GluR1 receptors and in the effect of kainic acid treatment in rat brain. Neuroscience 81 4 (1997) 1123-1135
4. Blythe S.N., Atherton J.F., and Bevan M.D. Synaptic activation of dendritic AMPA and NMDA receptors generates transient high-frequency firing in substantia nigra dopamine neurons in vitro. J. Neurophysiol. 97 4 (2007) 2837-2850
5. Chatha B.T., Bernard V., Streit P., and Bolam J.P. Synaptic localization of ionotropic glutamate receptors in the rat substantia nigra. Neuroscience 101 4 (2000) 1037-1051
6. Chen L.W., Wei L.C., Lang B., Ju G., and Chan Y.S. Differential expression of AMPA receptor subunits in dopamine neurons of the rat brain: a double immunocytochemical study. Neuroscience 106 1 (2001) 149-160
7. Choi W.S., Lee E.H., Chung C.W., Jung Y.K., Jin B.K., Kim S.U., Oh T.H., Saido T.C., and Oh Y.J. Cleavage of Bax is mediated by caspase-dependent or -independent calpain activation in dopaminergic neuronal cells: protective role of Bcl-2. J. Neurochem. 77 (2001) 1531-1541
8. Crocker S.J., Smith P.D., Jackson-Lewis V., Lamba W.R., Hayley S.P., Grimm E., Callaghan S.M., Slack R.S., Melloni E., Przedborski S., Robertson G.S., Anisman H., Merali Z., and Park D.S. Inhibition of calpains prevents neuronal and behavioral deficits in an MPTP mouse model of Parkinson's disease. J. Neurosci. 23 10 (2003) 4081-4091
9. Dauer W. Neurotrophic factors and Parkinson's disease: the emergence of a new player?. Sci. STKE 411 (2007) pe60
10. Dluzen D.E., Gao X., Story G.M., Anderson L.I., Kucera J., and Walro J.M. Evaluation of nigrostriatal dopaminergic function in adult +/+ and +/- BDNF mutant mice. Exp. Neurol. 170 (2001) 121-128
11. Fumagalli F., Racagni G., and Riva M.A. Shedding light into the role of BDNF in the pharmacotherapy of Parkinson's disease. Pharmacogenomics J. 6 (2006) 95-104
12. Gharami K., Xie Y., An J.J., Tonegawa S., and Xu B. Brain-derived neurotrophic factor over-expression in the forebrain ameliorates Huntington's disease phenotypes in mice. J. Neurochem. 105 2 (2008) 369-379
13. Goffredo D., Rigamonti D., Tartari M., De Micheli A., Verderio C., Matteoli M., Zuccato C., and Cattaneo E. Calcium-dependent cleavage of endogenous wild-type huntingtin in primary cortical neurons. J. Biol. Chem. 277 42 (2002) 39594-39598
14. Harrison P.J., and Weinberger D.R. Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence. Mol. Psychiatry 10 (2005) 40-68
15. Hayashi T., Umemori H., Mishina M., and Yamamoto T. The AMPA receptor interacts with and signals through the protein tyrosine kinase Lyn. Nature 397 (1999) 72-76
16. Hennegriff M., Arai A., Kessler M., Vanderklish P., Mutneja M.S., Rogers G., Neve R.L., and Lynch G. Stable expression of recombinant AMPA receptor subunits: binding affinities and effects of allosteric modulators. J. Neurochem. 68 (1997) 2424-2434
17. Higuchi M., Tomioka M., Takano J., Shirotani K., Iwata N., Masumoto H., Maki M., Itohara S., and Saido T.C. Distinct mechanistic roles of calpain and caspase activation in neurodegeneration as revealed in mice overexpressing their specific inhibitors. J. Biol. Chem. 280 15 (2005) 15229-15237
18. Ingvar M., Ambros-Ingerson J., Davis M., Granger R., Kessler M., Rogers G.A., Schehr R.S., and Lynch G. Enhancement by an ampakine of memory encoding in humans. Exp. Neurol. 146 (1997) 553-559
19. Iwakura Y., Nawa H., Sora I., and Chao M.V. Dopamine D1 receptor-induced signaling through TrkB receptors in striatal neurons. J. Biol. Chem. 283 23 (2008) 15799-15806
20. Jourdi H., Iwakura Y., Narisawa-Saito M., Ibaraki K., Xiong H., Watanabe M., Hayashi Y., Takei N., and Nawa H. Brain-derived neurotrophic factor signal enhances and maintains the expression of AMPA receptor-associated PDZ proteins in developing cortical neurons. Dev. Biol. 263 2 (2003) 216-230
21. Jourdi H., Lu X., Yanagihara T., Lauterborn J.C., Bi X., Gall C.M., and Baudry M. Prolonged positive modulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors induces calpain-mediated PSD-95/Dlg/ZO-1 protein degradation and AMPA receptor down-regulation in cultured hippocampal slices. J. Pharmacol. Exp. Ther. 314 1 (2005) 16-26
22. Jourdi H., Yanagihara T., Martinez U., Bi X., Lynch G., and Baudry M. Effects of positive AMPA receptor modulators on calpain-mediated spectrin degradation in cultured hippocampal slices. Neurochem. Int. 46 (2005) 31-40
23. Kelley A.E. Memory and addiction: shared neural circuitry and molecular mechanisms. Neuron 44 (2004) 161-179
24. Kuipers S.D., and Bramham C.R. Brain-derived neurotrophic factor mechanisms and function in adult synaptic plasticity: new insights and implications for therapy. Curr. Opin. Drug Discov. Devel. 9 (2006) 580-586
25. Langston J.W., and Irwin I. MPTP: current concepts and controversies. Clin. Neuropharmacol. 9 (1986) 485-507
26. Lauterborn J.C., Truong G.S., Baudry M., Bi X., Lynch G., and Gall C.M. Chronic elevation of brain-derived neurotrophic factor by ampakines. J. Pharmacol. Exp. Ther. 307 1 (2003) 297-305
27. Lee F.S., and Chao M.V. Activation of Trk neurotrophin receptors in the absence of neurotrophins. Proc. Natl. Acad. Sci. U.S.A. 98 6 (2001) 3555-3560
28. Lynch G. Glutamate-based therapeutic approaches: ampakines. Curr. Opin. Pharmacol. 6 1 (2007) 82-88
29. Lynch G., Kramar E.A., Rex C.S., Jia Y., Chappas D., Gall C.M., and Simmons D.A. Brain-derived neurotrophic factor restores synaptic plasticity in a knock-in mouse model of Huntington's disease. J. Neurosci. 27 16 (2007) 4424-4434
30. Madsen J.T., Jansen P., Hesslinger C., Meyer M., Zimmer J., and Gramsbergen J.B. Tetrahydrobiopterin precursor sepiapterin provides protection against neurotoxicity of 1-methyl-4-phenylpyridinium in nigral slice cultures. J. Neurochem. 85 (2003) 214-223
31. Murray T.K., Whalley K., Robinson C.S., Ward M.A., Hicks C.A., Lodge D., Vandergriff J.L., Baumbarger P., Siuda E., Gates M., Ogden A.M., Skolnick P., Zimmerman D.M., Nisenbaum E.S., Bleakman D., and O'Neill M.J. LY503430, a novel alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptor potentiator with functional, neuroprotective and neurotrophic effects in rodent models of Parkinson's disease. J. Pharmacol. Exp. Ther. 306 2 (2003) 752-762
32. O'Neill M.J., Murray T.K., Whalley K., Ward M.A., Hicks C.A., Woodhouse S., Osborne D.J., and Skolnick P. Neurotrophic actions of the novel AMPA receptor potentiator, LY404187, in rodent models of Parkinson's disease. Eur. J. Pharmacol. 486 2 (2004) 163-174
33. O'Neill M.J., Murray T.K., Clay M.P., Lindstrom T., Yang C.R., and Nisenbaum E.S. LY503430: pharmacology, pharmacokinetics, and effects in rodent models of Parkinson's disease. CNS Drug. Rev. 11 1 (2005) 77-96
34. Okazawa H., Murata M., Watanabe M., Kamei M., and Kanazawa I. Dopaminergic stimulation up-regulates the in vivo expression of brain-derived neurotrophic factor (BDNF) in the striatum. FEBS Lett. 313 (1992) 138-142
35. Rajagopal R., and Chao M.V. A role for Fyn in Trk receptor transactivation by G-protein-coupled receptor signaling. Mol. Cell. Neurosci. 33 1 (2006) 36-46
36. Scharfman H.E., and MacLusky N.J. The influence of gonadal hormones on neuronal excitability, seizures, and epilepsy in the female. Epilepsia 47 9 (2006) 1423-1440
37. Spina M.B., Squinto S.P., Miller J., Lindsay R.M., and Hyman C. Brain-derived neurotrophic factor protects dopamine neurons against 6-hydroxydopamine and N-methyl-4-phenylpyridinium ion toxicity: involvement of the glutathione system. J. Neurochem. 59 (1992) 99-106
38. del Toro D., Canals J.M., Ginés S., Kojima M., Egea G., and Alberch J. Mutant huntingtin impairs the post-Golgi trafficking of brain-derived neurotrophic factor but not its Val66Met polymorphism. J. Neurosci. 26 49 (2006) 12748-12757
39. Toyooka K., Iritani S., Makifuch T., Shirakawa O., Kitamura N., Maeda K., Nakamura R., Niizato K., Watanabe M., Kakita A., Takahashi H., Someya T., and Nawa H. Selective reduction of a PDZ protein, SAP-97, in the prefrontal cortex of patients with chronic schizophrenia. J. Neurochem. 83 (2002) 797-806
40. Tsuji T., and Shimohama S. Protein degradation in Alzheimer's disease and aging of the brain. Prog. Mol. Subcell. Biol. 29 (2002) 43-60
41. Xia Y.F., Kessler M., and Arai A.C. Positive alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor modulators have different impact on synaptic transmission in the thalamus and hippocampus. J. Pharmacol. Exp. Ther. 313 1 (2005) 277-285
42. Xiong H., Futamura T., Jourdi H., Zhou H., Takei N., Diverse-Pierluissi M., Plevy S., and Nawa H. Neurotrophins induce BDNF expression through the glutamate receptor pathway in neocortical neurons. Neuropharmacology 42 7 (2002) 903-912
43. Zhou M., and Baudry M. Developmental changes in NMDA neurotoxicity reflect developmental changes in subunit composition of NMDA receptors. J. Neurosci. 26 11 (2006) 2956-2963